The Florida Senate
BILL ANALYSIS AND FISCAL IMPACT STATEMENT
(This document is based on the provisions contained in the legislation as of the latest date listed below.)
Prepared By: The Professional Staff of the Committee on Children, Families, and Elder Affairs
BILL: CS/SB 1636
INTRODUCER: Children, Families, and Elder Affairs and Senator Gruters
SUBJECT: Substance Use Disorder Treatment Services
DATE: January 24, 2024 REVISED:
ANALYST STAFF DIRECTOR REFERENCE ACTION
1. Hall Tuszynski CF Fav/CS
2. AHS
3. FP
Please see Section IX. for Additional Information:
COMMITTEE SUBSTITUTE - Substantial Changes
I. Summary:
CS/SB 1636 creates the Substance Use Disorder Housing Advisory Council, which has the
primary function of conducting a study, with the aid of the University of South Florida College
of Public Health, to evaluate the national best practice standards from the Substance Abuse and
Mental Health Services Administration, with the goal of removing obstacles to therapeutic
housing within this state to be in compliance with federal law.
The bill also requires the Council to conduct a review of statewide zoning codes to determine
what effect, if any, local laws have on the ability of private sector licensed service providers to
provide modern, evidence-based, effective treatment and ancillary therapeutic housing to persons
in this state.
The bill details membership and appointment requirements of the council and requires a
preliminary report with findings and recommendations on July 1, 2027 and a final report on
September 1, 2027. The statute repeals on September 1, 2027.
The bill makes patient records in recovery residences confidential under s. 397.501(7), F.S.
The bill also prohibits any local law, ordinance, or regulation from regulating the duration or
frequency of a resident’s stay in certain certified recovery residences in areas where multifamily
uses are allowed.
BILL: CS/SB 1636 Page 2
The bill provides for an effective date of July 1, 2024.
II. Present Situation:
Substance abuse is the harmful or hazardous use of psychoactive substances, including alcohol
and illicit drugs.1 According to the Diagnostic and Statistical Manual of Mental Disorders, fifth
Edition (DSM-5), a diagnosis of substance use disorder (SUD) is based on evidence of impaired
control, social impairment, risky use, and pharmacological criteria.2 SUD occurs when an
individual chronically uses alcohol or drugs, resulting in significant impairment, such as health
problems, disability, and failure to meet major responsibilities at work, school, or home.3
Repeated drug use leads to changes in the brain’s structure and function that can make a person
more susceptible to developing a substance abuse disorder.4 Imaging studies of brains belonging
to persons with SUD reveal physical changes in areas of the brain critical to judgment, decision
making, learning and memory, and behavior control.5
Among people aged 12 or older in 2021, 61.2 million people (or 21.9 percent of the population)
used illicit drugs in the past year.6 The most commonly used illicit drug was marijuana, which
52.5 million people used.7 In the past year:8
Nearly 2 in 5 young adults 18 to 25 used illicit drugs;
1 in 3 young adults 18 to 25 used marijuana;
9.2 million people 12 and older misused opioids;
46.3 million people aged 12 and older (16.5 percent of the population) met the applicable
DSM-5 criteria for having a substance use disorder, including 29.5 million who were
classified as having an alcohol use disorder and 24 million who were classified as having a
drug use disorder. The percentage was highest among young adults aged 18 to 25;
In 2021, 94% of people aged 12 or older with a substance use disorder did not receive any
treatment.9
1
The World Health Organization, Mental Health and Substance Abuse, available at
https://www.who.int/westernpacific/about/how-we-work/programmes/mental-health-and-substance-abuse (last visited
January 18, 2024); the National Institute on Drug Abuse (NIDA), The Science of Drug Use and Addiction: The Basics,
available at https://archives.nida.nih.gov/publications/media-guide/science-drug-use-addiction-basics (last visited January 18,
2024).
2
The National Association of Addiction Treatment Providers, Substance Use Disorder, available at
https://www.naatp.org/resources/clinical/substance-use-disorder (last visited January 18, 2024).
3
The Substance Abuse and Mental Health Services Administrator (The SAMHSA), Substance Use Disorders, available at
https://www.samhsa.gov/find-help/disorders (last visited January 18, 2024).
4
The NIDA, Drugs, Brains, and Behavior: The Science of Addiction, available at https://nida.nih.gov/publications/drugs-
brains-behavior-science-addiction/drug-misuse-addiction (last visited January 18, 2024).
5
Id.
6
U.S. Department of Health and Human Services, SAMHSA Announces National Survey on Drug Use and Health (NSDUH)
Results Detailing Mental Illness and Substance Use Levels in 2021, available at
https://www.hhs.gov/about/news/2023/01/04/samhsa-announces-national-survey-drug-use-health-results-detailing-mental-
illness-substance-use-levels-2021.html (last visited January 18, 2024).
7
Id.
8
Id.
9
Id.
BILL: CS/SB 1636 Page 3
In 2020, according to the National Center for Drug Abuse Statistics10, the specific drug
breakdowns were as follows:
More than 106,000 persons in the U.S. died from drug-involved overdose in 2021, including
illicit drugs and prescription opioids.11 The following graph shows the total number of U.S. drug
overdose deaths from 1999 to 2021.12 The bars overlaid by lines show the number of deaths by
gender.13
10
National Center for Drug Abuse Statistics, Drug Abuse Statistics, available at https://drugabusestatistics.org/ (last visited
January 18, 2024).
11
National Institute on Drug Abuse, Drug Overdose Death Rates, available at https://nida.nih.gov/research-topics/trends-
statistics/overdose-death-rates (last visited January 18, 2024).
12
Id.
13
Id.
BILL: CS/SB 1636 Page 4
National Overdose Deaths
Deaths involving synthetic opioids other than methadone (primarily fentanyl) continued to rise
with 70,601 overdose deaths reported in 2021.14 Those involving stimulants, including cocaine
or psychostimulants with abuse potential (primarily methamphetamine), also continued to
increase with 32,537 overdose deaths in 2021.15
14
Id.
15
Id.
BILL: CS/SB 1636 Page 5
Substance Abuse Treatment in Florida
In the early 1970s, the federal government enacted laws creating formula grants for states to
develop continuums of care for individuals and families affected by substance abuse.16 The laws
resulted in separate funding streams and requirements for alcoholism and drug abuse. In response
to the laws, the Florida Legislature enacted chs. 396 and 397, F.S., relating to alcohol and drug
abuse, respectively.17 Each of these laws governed different aspects of addiction, and thus, had
different rules promulgated by the state to fully implement the respective pieces of legislation.18
However, because persons with substance abuse issues often do not restrict their misuse to one
substance or another, having two separate laws dealing with the prevention and treatment of
addiction was cumbersome and did not adequately address Florida’s substance abuse problem.19
In 1993, legislation was adopted to combine ch. 396 and 397, F.S., into a single law, the Hal S.
Marchman Alcohol and Other Drug Services Act (Marchman Act).20
The Marchman Act encourages individuals to seek services on a voluntary basis within the
existing financial and space capacities of a service provider.21 However, denial of addiction is a
prevalent symptom of SUD, creating a barrier to timely intervention and effective treatment. 22
As a result, treatment typically must stem from a third party providing the intervention needed
for SUD treatment.23
The Department of Children and Families (DCF) administers a statewide system of safety-net
services for substance abuse and mental health (SAMH) prevention, treatment, and recovery for
children and adults who are otherwise unable to obtain these services. Services are provided
based upon state and federally-established priority populations.24 The DCF provides treatment
for SUD through a community-based provider system offering detoxification, treatment, and
recovery support for individuals affected by substance misuse, abuse, or dependence.25
Detoxification Services: Detoxification services use medical and clinical procedures to assist
individuals and adults as they withdraw from the physiological and psychological effects of
substance abuse.26
16
The DCF, Baker Act and Marchman Act Project Team Report for Fiscal Year 2016-2017, p. 4-5. (on file with the Senate
Children, Families, and Elder Affairs Committee).
17
Id.
18
Id.
19
Id.
20
Chapter 93-39, s. 2, L.O.F., codified as ch. 397, F.S.
21
See ss. 397.601(1) and (2), F.S., An individual who wishes to enter treatment may apply to a service provider for voluntary
admission. Within the financial and space capabilities of the service provider, the individual must be admitted to treatment
when sufficient evidence exists that he or she is impaired by substance abuse and his or her medical and behavioral
conditions are not beyond the safe management capabilities of the service provider.
22
Darran Duchene and Patrick Lane, Fundamentals of the Marchman Act, Risk RX, Vol. 6 No. 2 (Apr. – Jun. 2006) State
University System of Florida Self-Insurance Programs, available at https://flbog.sip.ufl.edu/risk-rx-article/fundamentals-of-
the-marchman-act/ (last visited January 18, 2024)(hereinafter cited as “fundamentals of the Marchman Act”).
23
Id.
24
See ch. 394 and 397, F.S.
25
The DCF, Treatment for Substance Abuse, available at https://www.myflfamilies.com/services/samh/treatment (last visited
January 18, 2024).
26
Id.
BILL: CS/SB 1636 Page 6
Treatment Services: Treatment services27 include a wide array of assessment, counseling,
case management, and support that are designed to help individuals who have lost their
abilities to control their substance use on their own and require formal, structured
intervention and support.28
Recovery Support: Recovery support services, including transitional housing, life skills
training, parenting skills, and peer-based individual and group counseling, are offered during
and following treatment to further assist individuals in their development of the knowledge
and skills necessary to maintain their recovery.29
Licensure of Substance Abuse Service Providers
The DCF regulates substance use disorder treatment by licensing individual treatment
components under ch. 397, F.S., and Rule 65D-30, F.A.C. Licensed service components include
a continuum of substance abuse prevention30, intervention31, and clinical treatment services.32
Clinical treatment is a professionally directed, deliberate, and planned regimen of services and
interventions that are designed to reduce or eliminate the misuse of drugs and alcohol and
promote a healthy, drug-free lifestyle.33 “Clinical treatment services” include, but are not limited
to, the following licensable service components:
Addictions receiving facility.
Day or night treatment.
Day or night treatment with community housing.
Detoxification.
Intensive inpatient treatment.
Intensive outpatient treatment.
Medication-assisted treatment for opiate addiction.
Outpatient treatment.
Residential treatment.34
27
Id. Research indicates that persons who successfully complete substance abuse treatment have better post-treatment
outcomes related to future abstinence, reduced use, less involvement in the criminal justice system, reduced involvement in
the child-protective system, employment, increased earnings, and better health.
28
Id.
29
Id.
30
Section 397.311(26)(c), F.S. “Prevention” is defined as “a process involving strategies that are aimed at the individual,
family, community, or substance and that preclude, forestall, or impede the development of substance use problems and
promote responsible lifestyles.” See also The DCF, Substance Abuse Prevention,
https://www.myflfamilies.com/services/samh/substance-abuse-prevention (last visited January 19, 2024).
31
Section 397.311(26)(b), F.S. “Intervention” is defined as “structured services directed toward individuals or groups at risk
of substance abuse and focused on reducing or impeding those factors associated with the onset or the early stages of
substance abuse and related problems.”
32
Section 397.311(26), F.S.
33
Section 397.311(26)(a), F.S.
34
Id.
BILL: CS/SB 1636 Page 7
Application for Licensure
Individuals applying for licensure as substance abuse service providers must submit applications
on specified forms provided, and in accordance with rules adopted, by the DCF.35 Applications
must include, at a minimum:
Information establishing the name and address of the applicant service provider and its
director, and also of each member, owner, officer, and shareholder, if any.
Information establishing the competency and ability of the applicant service provider and its
director to carry out the requirements of ch. 397, F.S.
Proof satisfactory to the DCF of the applicant service provider’s financial ability and
organizational capability to operate in accordance with ch. 397, F.S.
Proof of liability insurance coverage in amounts set by the DCF by rule.
Sufficient information to conduct background screening for all owners, directors, chief
financial officers, and clinical supervisors as provided in s. 397.4073, F.S.
Proof of satisfactory fire, safety, and health inspections, and compliance with local zoning
ordinances. Service providers operating under a regular annual license within which to meet
local zoning requirements. Applicants for a new license must demonstrate proof of
compliance with zoning requirements prior to the DCF issuing a probationary license.
A comprehensive outline of the proposed services, including sufficient detail to evaluate
compliance with clinical and treatment best practices, for:
o Any new applicant; or
o Any licensed service provider adding a new licensable service component.
Proof of the ability to provide services in accordance with the DCF rules.
Any other information that the DCF finds necessary to determine the applicant’s ability to
carry out its duties under this chapter and applicable rules.36
Florida does not license recovery services; instead, in 2015, the Legislature enacted sections
397.487-397.4872, F.S., which establishes voluntary certification programs for recovery
residences and recovery residence administrators, implemented by private credentialing
entities.37
Recovery Residences
Recovery residences (also known as “sober homes, “sober living homes,” “Oxford Houses,” or
“Halfway Houses”) are non-medical settings designed to support recovery from substance use
disorders, providing a substance-free living environment commonly used to help individuals
transition from highly structured residential treatment programs back into their day-to-day lives
(e.g., obtaining employment and establishing more permanent residence).38 Virtually all
35
Section 397.403(1), F.S.
36
Id.
37
Chapter 2015-100, L.O.F.
38
Recovery Research Institute, Recovery Residences, available at https://www.recoveryanswers.org/resource/recovery-
residences/ (last visited January 18, 2024). Substance abuse prevention is achieved through the use of ongoing strategies such
as increasing public awareness and education, community-based processes and evidence-based practices. These prevention
programs are focused primarily on youth, and, in recent years, have shifted to the local level, giving individual communities
the opportunity to identify their own unique prevention needs and develop